Radiographic Surveillance of Patients with Non-BRCA1/2 Pathogenic Variants

被引:0
|
作者
Laura Hudson
Nicole Gower
Stacy Lenarcic
Sally J. Trufan
Richard L. White
机构
[1] Levine Cancer Institute,Division of Surgical Oncology, Department of Surgery, Carolinas Medical Center
[2] Levine Cancer Institute,Department of Cancer Biostatistics
[3] Levine Cancer Institute,Department of Genetics
来源
关键词
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:2248 / 2254
页数:6
相关论文
共 50 条
  • [1] Radiographic Surveillance of Patients with Non-BRCA1/2Pathogenic Variants
    Hudson, Laura
    Gower, Nicole
    Lenarcic, Stacy
    Trufan, Sally J.
    White, Richard L., Jr.
    ANNALS OF SURGICAL ONCOLOGY, 2020, 27 (07) : 2248 - 2254
  • [2] NON-BRCA1/2 PATHOGENIC/LIKELY PATHOGENIC VARIANTS DETECTED IN 2.6% OF PATIENTS WITH OVARIAN, FALLOPIAN TUBE OR PRIMARY PERITONEAL CANCER
    Mesaric, V. A.
    Staric, K. Drusany
    Hotujec, S.
    Strojnik, K.
    Blatnik, A.
    Banjac, M.
    Skof, E.
    Stegel, V.
    Novakovic, S.
    Krajc, M.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2021, 31 : A250 - A250
  • [3] Tyrer-Cuzick Lifetime Risk Is Not Associated with Non-BRCA1/2 Pathogenic Variants for Breast Carcinoma
    Rao, Divya
    Wernecke, Chloe
    Baron, Lisa
    Cai, Steven
    Beitsch, Peter
    Patel, Rakesh
    Whitworth, Pat
    Rosen, Barry
    Tran, Nhan
    Hughes, Kevin
    Baron, Paul
    ANNALS OF SURGICAL ONCOLOGY, 2023, 30 (SUPPL 2) : S317 - S318
  • [4] Prevalence of pathogenic non-BRCA1/2 gene variants in patients with suspected hereditary breast and ovarian cancer at a referral hospital in northeastern
    Sant'Ana, Rosane Oliveira
    Picanco-Albuquerque, Clarissa Gondim
    de Lima Silva-Fernandes, Isabelle Joyce
    de Barros Silva, Paulo Goberlanio
    Barbosa Bezerra, Maria Julia
    dos Santos Luciano, Maria Claudia
    Alves Lima, Marcos Venicio
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [5] Frequency of heterozygous germline pathogenic variants in genes for Fanconi anemia in patients with non-BRCA1/BRCA2 breast cancer: a meta-analysis
    Alter, Blanche P.
    Best, Ana F.
    BREAST CANCER RESEARCH AND TREATMENT, 2020, 182 (02) : 465 - 476
  • [6] Frequency of heterozygous germline pathogenic variants in genes for Fanconi anemia in patients with non-BRCA1/BRCA2 breast cancer: a meta-analysis
    Blanche P. Alter
    Ana F. Best
    Breast Cancer Research and Treatment, 2020, 182 : 465 - 476
  • [7] Correction to: Frequency of heterozygous germline pathogenic variants in genes for Fanconi anemia in patients with non-BRCA1/BRCA2 breast cancer: a meta-analysis
    Blanche P. Alter
    Ana F. Best
    Breast Cancer Research and Treatment, 2020, 183 : 491 - 491
  • [8] Pathogenic germline variants in non-BRCA1/2 homologous recombination genes in ovarian cancer: Analysis of tumor phenotype and survival
    Kahn, Ryan M.
    Selenica, Pier
    Boerner, Thomas
    Roche, Kara Long
    Xiao, Yonghong
    Sia, Tiffany Y.
    Maio, Anna
    Kemel, Yelena
    Sheehan, Margaret
    -Mullen, Erin Salo
    Breen, Kelsey E.
    Zhou, Qin
    Iasonos, Alexia
    Grisham, Rachel N.
    O'Cearbhaill, Roisin E.
    Chi, Dennis S.
    Berger, Michael F.
    Kundra, Ritika
    Schultz, Nikolaus
    Ellenson, Lora H.
    Stadler, Zsofia K.
    Offit, Kenneth
    Mandelker, Diana
    Aghajanian, Carol
    Zamarin, Dmitriy
    Sabbatini, Paul
    Weigelt, Britta
    Liu, Ying L.
    GYNECOLOGIC ONCOLOGY, 2024, 180 : 35 - 43
  • [9] Prevalence of BRCA1 and BRCA2 pathogenic and likely pathogenic variants in non-selected ovarian carcinoma patients in Brazil
    Cotrim, Deborah Porto
    Goncalves Ribeiro, Adriana Regina
    Paixao, Daniele
    de Queiroz Soares, Diogo Cordeiro
    Jbili, Rima
    Pandolfi, Natasha Carvalho
    Cezana, Camila
    Mauro, Carine de Cassia
    Mantoan, Henrique
    Bovolim, Graziele
    de Brot, Louise
    Torrezan, Giovana Tardin
    Carraro, Dirce Maria
    Baiocchi, Glauco
    da Cruz Formiga, Maria Nirvana
    da Costa, Alexandre A. B. A.
    BMC CANCER, 2019, 19 (1)
  • [10] Prevalence of BRCA1 and BRCA2 pathogenic and likely pathogenic variants in non-selected ovarian carcinoma patients in Brazil
    Deborah Porto Cotrim
    Adriana Regina Gonçalves Ribeiro
    Daniele Paixão
    Diogo Cordeiro de Queiroz Soares
    Rima Jbili
    Natasha Carvalho Pandolfi
    Camila Cezana
    Carine de Cássia Mauro
    Henrique Mantoan
    Graziele Bovolim
    Louise de Brot
    Giovana Tardin Torrezan
    Dirce Maria Carraro
    Glauco Baiocchi
    Maria Nirvana da Cruz Formiga
    Alexandre A. B. A. da Costa
    BMC Cancer, 19